FLSM
EPIX

Frazier Life Sciences Management’s ESSA Pharma EPIX Stock Holding History

Frazier Life Sciences Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-605,141
Closed -$1.52M – 50
2022
Q4 		$1.52M Sell
605,141
-87,769
-13% -$252K 0.09% 41
2022
Q3 		$1.26M Hold
692,910
– – 0.1% 40
2022
Q2 		$2.18M Hold
692,910
– – 0.21% 36
2022
Q1 		$4.28M Buy
+692,910
New +$6.09M 0.36% 36

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Frazier Life Sciences Management's EPIX Position: Q1 2023 in Review

Frazier Life Sciences Management sold out of ESSA Pharma (EPIX) in Q1 2023, closing a stake of 605,141 shares — an estimated $1.52M sold.

Frazier Life Sciences Management first reported a position in EPIX in Q1 2022 and held it in 4 quarters. The position peaked at $4.28M in Q1 2022. 37 funds tracked by Wall St. Rank hold EPIX as of Q1 2023.

  • Frazier Life Sciences Management reported no remaining ESSA Pharma position as of Q1 2023 after selling out during the quarter.
  • Frazier Life Sciences Management sold 605,141 ESSA Pharma shares in Q1 2023, an estimated $1.52M.
  • Frazier Life Sciences Management first reported a position in ESSA Pharma in Q1 2022 and held it in 4 quarters.
  • Frazier Life Sciences Management's ESSA Pharma position peaked at $4.28M in Q1 2022.
  • 37 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2023.

Based on Frazier Life Sciences Management's 13F filing for Q1 2023, filed 15 May 2023.